Interest of Ineurope® syringe for nerve agent intoxication;Intérêt de la seringue Ineurope® devant une intoxication par neurotoxique de guerre

Annales Francaises d'Anesthesie et de Reanimation

Volumn 28, Issue 5, 2009, Pages 482-488

  Rousseau, J M ^a   Besse Bardot, I ^b   Franck, L ^a   Libert, N ^a   Lallement, G ^c   Clair, P ^b  

^a SERVICE D ENDOCRINOLOGIE   (France)

^b Pharmacie centrale des armées ^*  (France)

^c Centre de Recherches du Service de Sante des Armees   (France)

Author keywords

Chemical weapons; Nerve agents; Organophosphate poisoning; Terrorism

Indexed keywords

NERVE GAS; PRALIDOXIME MESILATE; SARIN; SOMAN; TABUN;

ARTICLE; ASSISTED VENTILATION; CHEMICAL WARFARE; EMERGENCY CARE; ENDOTRACHEAL INTUBATION; FRANCE; GAS POISONING; HEART DISEASE; HUMAN; MILITARY MEDICINE; NEUROTOXICITY; PALLIATIVE THERAPY; PROCESS DEVELOPMENT; SELF INJECTION; SYRINGE;

AUTONOMIC NERVOUS SYSTEM DISEASES; CHEMICAL WARFARE AGENTS; CHOLINESTERASE REACTIVATORS; FRANCE; HUMANS; MILITARY PERSONNEL; SYRINGES;

EID: 67349119971     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2009.02.039     Document Type: Article

References (21)

1. Renaudeau C. Les agressifs chimiques de guerre. In: de Revel T. (Ed). Menace terroriste approche médicale (2005), John Libbey Eurotext 317-326
2. Compagnon J. La Convention des armes chimiques remise sur rails. Études politiques stratégiques militaires économiques scientifiques. Def Nat 12 (1997) 29-36
3. Nozaki H., Aikawa N., Shinozawa Y., Hori S., Fujishima S., Takuma K., et al. Sarin poisoning in Tokyo subway. Lancet 345 (1995) 980-981
4. Okumura T., Takasu N., Ishimatsu S., Miyanoki S., Mitsuhashi A., Kumada K., et al. Report on 640 victims of the Tokyo subway Sarin attack. Ann Emerg Med 28 (1996) 129-135
5. Rousseau J.M., Rüttimann M., and Brinquin L. Intoxications aiguës par neurotoxiques organophosphorés : insecticides et armes chimiques. Ann Fr Anesth Reanim 19 (2000) 588-598
6. Taylor P. Anticholinesterase agents. In: Goodman A.G., Rail T.W., and Nies A.S. (Eds). The pharmacological basis of therapeutics (1990), Pergamon Press, New York 131-149
7. Cavallo J.D., Kowalski J.J., Renaudeau C., and Tréguier J.Y. In: Buisson Y. (Ed). Les risques NRBC, savoir pour agir (2004), Édition Xavier Montauban 106
8. Hachelaf M., Capellier G., and Danel V. Les toxidromes. Reanimation 15 (2006) 364-369
9. Kales S.N., and Christiani D.C. Acute chemical Emergencies. N Engl J Med 350 (2004) 800-808
10. Lallement G., Rüttimann M., and Dorandeu F. Les neurotoxiques organophosphorés. In: de Revel T. (Ed). Menace terroriste approche médicale (2005), John Libbey Eurotext 327-337
11. Flaishon R., Sotman A., Ben-Abraham R., Rudick V., Varssano D., and Weinbroum. Antichemical protective gear prolongs time to successful airway management: a randomized, crossover study in humans. Anesthesiology 100 (2004) 260-266
12. Berkenstadt H., Ziv A., Barsuk D., Levine I., Cohen A., and Vardi A. The use of advanced simulation in the training of anesthesiologists to treat chemical warfare casualties. Anesth Analg 96 (2003) 1739-1742
13. Vardi A., Berkenstadt H., Levin I., Bentencur A., and Ziv A. Intraosseous vascular access in the treatment of chemical warfare casualties assessed by advanced simulation: proposed alteration of treatment protocol. Anesth Analg 98 (2004) 1753-1758
14. Blanchet J.M., Noto R., Pailler F.M., Renaudeau C., and Ricordel. Les agressions chimiques (1997), France-Sélection, Paris
15. Chen J.W., and Wasterlain C.G. Status epilepticus: pathophysiology and management in adults. Lancet Neurol 5 (2006) 246-256
16. Contreras C.M., Marvan M.L., Mexicano G., Puente A., and Morfin A. Ketamine antagonizes toxic action of anticholinesterasic agents. Bol Estud Med Biol Mex 38 (1990) 10-15
17. Lallement G., Renault F., Baubichon D., Peoc'h M., Burckhart M.F., Galonnier M., et al. Compared efficacy of diazepam or avizafone to prevent soman-induced electroencephalographic disturbances and neuropathology in primates: relationship to plasmatic benzodiazépine pharmakocinetics. Arch Toxicol 74 (2000) 480-486
18. Lallement G., Masqueliez C., Baubichon D., Cassegrain N., Renaudeau P., and Clair P. Protection against soman-induced lethality of the antidote combination atropine-pralidoxime-prodiazepam packaged as a freeze-dried form. J Med Chem Def 2 (2004) 1-11
19. Décision du directeur général de l'Afssaps du 24 novembre 2006 fixant les règles de bonnes pratiques cliniques portant sur des médicaments à usage humain. www.legifrance.gouv.fr (site consulté en novembre 2008).
20. Emea. ICH S7A. Safety pharmacologic studies for human pharmaceuticals CPMP/ICH/539/00 novembre 2000:1-10. www.emea.europa.eu/pdfs/human/ich/059300en.pdf (site consulté en novembre 2008).
21. Besse Bardot I., Clair P., Lallement G., Mendes Oustric A.C., Bardot S., Rousseau J.M., et al. L'autorisation de mise sur le marché pour l'Ineurope® : exemple d'une coopération transversale réussie au sein du service de santé des armées. SFSTP Pharma Pratiques (2008) 1-16